NASDAQ:ATOS   Atossa Therapeutics, Inc.

Possible Scenario: Long
Target Prices TP1:3$, TP2: 5$, TP3: 7$
Timeframe: October 2023
Evidence: Price Actions, Money Flow

no pain, no gain
Unveiling illusions, revealing wealth

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.